WallStreetZenWallStreetZen

NASDAQ: UNCY
Unicycive Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

UNCY earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$31.4M
Current Profit Margin
0%

UNCY Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when UNCY announces earnings.

UNCY Return on Assets

Current Company
-150.1%
Current Industry
2.9%
UNCY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

UNCY Return on Capital Employed

Current Company
911.22%
Current Industry
19.5%
UNCY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UNCY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
UNCY$0.00-$30.18M-$31.41MN/AN/A
VYNE$424.00k-$28.45M-$28.45M-34.79%N/A
OKYO$0.00-$13.18M-$13.27MN/AN/A
XLO$0.00-$74.50M-$76.40MN/AN/A
CARA$20.97M-$115.58M-$118.51M+9.26%N/A
View Top Biotech Stocks

UNCY earnings dates

Next earnings date
May 9, 2024

Unicycive Therapeutics Earnings & Revenue FAQ

What were UNCY's earnings last quarter?

On Invalid Date, Unicycive Therapeutics (NASDAQ: UNCY) reported Q4 2023 earnings per share (EPS) of -$0.16, up 54.29% year over year. Total Unicycive Therapeutics earnings for the quarter were -$7.80 million. In the same quarter last year, Unicycive Therapeutics's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.

What was UNCY's earnings growth in the past year?

As of Q2 2024, Unicycive Therapeutics's earnings has grown year over year. Unicycive Therapeutics's earnings in the past year totalled -$31.41 million.

What is UNCY's earnings date?

Unicycive Therapeutics's earnings date is Invalid Date. Add UNCY to your watchlist to be reminded of UNCY's next earnings announcement.

What was UNCY's revenue last quarter?

On Invalid Date, Unicycive Therapeutics (NASDAQ: UNCY) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Unicycive Therapeutics's revenue was $0.00.

What was UNCY's revenue growth in the past year?

As of Q2 2024, Unicycive Therapeutics's revenue has grown null year over year. Unicycive Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.